All Dr. Martens articles
-
Infographics & DataGlobal leaders in branded casual footwear 2022
Found out who were the leading casual footwear brands in 2022 in our latest graphic.
-
News briefsDr. Martens commands a high Ebitda multiple with its IPO
Dr. Martens is being valued between £3.3-3.7 billion (€3.7bn-$4.5bn to €4.2bn-$5.1bn) in its planned public offering on the London Stock Exchange, whichis already fully booked. The valuation implies a multiple of over 17 times Ebitda, as the company generated Ebitda of £184 million (€204.2m-$248.3m) on revenues of £672 million (€745.8m-$907m) ...
-
ArticleGrowing Dr. Martens plans an IPO in London
Dr. Martens plans to float on the London Stock Exchange as it looks to expand its offering and drive e-commerce sales, as reported in our sister publication Shoe Intelligence, which covers non-athletic footwear. The company behind the iconic British boot brand expects an eventual free float of 25 percent ...